http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344724100029&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=8e1609b174ce4e31116a60747a720701Medicine, General & InternalSCI(E)PubMed中国科技核心期刊(ISTIC)中国科学引文数据库(CSCD)0ARTICLEmd_ye@sina.com203676-367712
Heterogeneous expression or amplification is a challenge to HER2 diagnostics. A guideline defines he...
textabstractAims: Equivocal human epidermal growth factor receptor 2 protein (HER2) (2+) immunohisto...
AIMS: To investigate whether alterations of the HER2 gene occur more frequently in histologically un...
b s t r a c t We evaluated intratumoral heterogeneity of 30 ductal breast carcinomas with HER2/neu a...
BACKGROUND: HER2 is overexpressed and amplified in approximately 15% of invasive breast cancers, and...
Targeted therapy for patients with HER2‐positive (HER2+) breast cancer has improved overall survival...
Abstract: We evaluated intratumoral heterogeneity of 30 ductal breast carcinomas with HER2/neu ampli...
Targeted therapy for patients with HER2‐positive (HER2+) breast cancer has improved overall survival...
Breast cancer (BC) is a heterogeneous disease that varies in presentation, morphological features, b...
There is burgeoning evidence to suggest that tumor evolution follows the laws of Darwinian evolution...
Intratumour heterogeneity fuels carcinogenesis and allows circumventing specific targeted therapies....
The main obstacle for designing effective treatment approaches in breast cancer is the extensive and...
Intratumour heterogeneity fuels carcinogenesis and allows circumventing specific targeted therapies...
This study aimed to determine the incidence and characteristics of HER-2 gene heterogeneity in invas...
International and national guidelines highlight the importance of accuracy, reproducibility, and qu...
Heterogeneous expression or amplification is a challenge to HER2 diagnostics. A guideline defines he...
textabstractAims: Equivocal human epidermal growth factor receptor 2 protein (HER2) (2+) immunohisto...
AIMS: To investigate whether alterations of the HER2 gene occur more frequently in histologically un...
b s t r a c t We evaluated intratumoral heterogeneity of 30 ductal breast carcinomas with HER2/neu a...
BACKGROUND: HER2 is overexpressed and amplified in approximately 15% of invasive breast cancers, and...
Targeted therapy for patients with HER2‐positive (HER2+) breast cancer has improved overall survival...
Abstract: We evaluated intratumoral heterogeneity of 30 ductal breast carcinomas with HER2/neu ampli...
Targeted therapy for patients with HER2‐positive (HER2+) breast cancer has improved overall survival...
Breast cancer (BC) is a heterogeneous disease that varies in presentation, morphological features, b...
There is burgeoning evidence to suggest that tumor evolution follows the laws of Darwinian evolution...
Intratumour heterogeneity fuels carcinogenesis and allows circumventing specific targeted therapies....
The main obstacle for designing effective treatment approaches in breast cancer is the extensive and...
Intratumour heterogeneity fuels carcinogenesis and allows circumventing specific targeted therapies...
This study aimed to determine the incidence and characteristics of HER-2 gene heterogeneity in invas...
International and national guidelines highlight the importance of accuracy, reproducibility, and qu...
Heterogeneous expression or amplification is a challenge to HER2 diagnostics. A guideline defines he...
textabstractAims: Equivocal human epidermal growth factor receptor 2 protein (HER2) (2+) immunohisto...
AIMS: To investigate whether alterations of the HER2 gene occur more frequently in histologically un...